M
Marc A. Pfeffer
Researcher at Brigham and Women's Hospital
Publications - 815
Citations - 143710
Marc A. Pfeffer is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 166, co-authored 765 publications receiving 133043 citations. Previous affiliations of Marc A. Pfeffer include Partners HealthCare & University of Miami.
Papers
More filters
Journal ArticleDOI
Natural biventricular hypertrophy in normotensive rats. I. Physical and hemodynamic characteristics.
TL;DR: A subset of the WKY demonstrating an inheritable transmission of biventricular cardiac hypertrophy (BVH) has been identified, and this natural development of BVH appears to be in response to an increased cardiac output.
Journal ArticleDOI
Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical Trials
Jonathan W. Cunningham,Muthiah Vaduganathan,Brian Claggett,Jenine E. John,Akshay S. Desai,Eldrin F. Lewis,Michael R. Zile,Peter E. Carson,Pardeep S. Jhund,Lars Køber,Bertram Pitt,Sanjiv J. Shah,Karl Swedberg,Inder S. Anand,Salim Yusuf,John J.V. McMurray,Marc A. Pfeffer,Scott D. Solomon +17 more
TL;DR: Prior MI in HFpEF is associated with greater CV and sudden death but similar risk of HF outcomes, and the importance of primary and secondary prevention of MI in patients with HFp EF is highlighted.
Journal ArticleDOI
Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarction.
Anil Verma,Marc A. Pfeffer,Hicham Skali,Jean L. Rouleau,Aldo P. Maggioni,John J.V. McMurray,Robert M. Califf,Eric J. Velazquez,Scott D. Solomon +8 more
TL;DR: Predictors of death and development of heart failure were assessed in 603 patients from the Valsartan in Acute Myocardial Infarction (VALIANT) echocardiographic substudy, finding that measures of cardiac structure and function beyond LVEF provide important prognostic information beyond the clinical assessment.
Journal ArticleDOI
Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: An analysis of the TREAT (trial to reduce cardiovascular events with aranesp therapy) placebo arm
Hicham Skali,Julie Lin,Marc A. Pfeffer,Chao-Yin Chen,Mark E. Cooper,John J.V. McMurray,Allen R. Nissenson,Allen R. Nissenson,Giuseppe Remuzzi,Jerome Rossert,Patrick S. Parfrey,Nairne Scott-Douglas,Ajay K. Singh,Robert D. Toto,Hajime Uno,Peter Ivanovich +15 more
TL;DR: Most patients with moderate anemia, non-dialysis-dependent CKD, and type 2 diabetes are able to maintain a stable Hb level without implementing long-term erythropoiesis-stimulating agent therapy.
Journal ArticleDOI
Blood pressure in heart failure: a love-hate relationship.
TL;DR: The sphygmomanometer remains the key tool for titrating antihypertensive therapy to achieve and ensure lowering blood pressure in patients with hypertension.